Discover the groundbreaking research combining DNase I with CAR T-cell therapy to enhance cancer treatment efficacy, suppress ...

Researchers at the University of Basel have developed CAR T-cells that target glioblastoma, a notoriously aggressive brain ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

T-cell therapy is a revolutionary immunotherapy approach in which T cells are genetically modified to express a receptor that ...

Researchers investigating ways to reduce exhaustion in cancer-fighting T-cells found that the Golgi apparatus can be used as a simple marker -- more Golgi means a more robust cell.

A Stanford Medicine trial has shown success with CAR-T cell therapy in shrinking deadly childhood brain tumors. For one ...

1Brain Tumor and Immune Cell Engineering Laboratory, Agora Cancer Research Center, Lausanne, Switzerland. 2Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland. 3Center for Translational Research ...

Yescarta – a CD19-directed genetically modified autologous T-cell immunotherapy investigated in the ZUMA-1 trial – is the first chimeric antigen receptor (CAR) T-cell therapy recommended for ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Chimeric antigen receptor ...

An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford ...